Manchester Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.5K | Sell |
400
-600
| -60% | -$29.2K | ﹤0.01% | 720 |
|
|
2025
Q1 | $34K | Hold |
1,000
| – | – | ﹤0.01% | 621 |
|
|
2024
Q4 | $39.4K | Hold |
1,000
| – | – | ﹤0.01% | 587 |
|
|
2024
Q3 | $47K | Hold |
1,000
| – | – | 0.01% | 549 |
|
|
2024
Q2 | $54K | Hold |
1,000
| – | – | 0.01% | 486 |
|
|
2024
Q1 | $68.2K | Hold |
1,000
| – | – | 0.01% | 436 |
|
|
2023
Q4 | $62.6K | Buy |
+1,000
| New | +$62.6K | 0.01% | 398 |
|
|
2022
Q1 | – | Sell |
-800
| Closed | -$61K | – | 1045 |
|
|
2021
Q4 | $61K | Hold |
800
| – | – | 0.01% | 390 |
|
|
2021
Q3 | $90K | Hold |
800
| – | – | 0.01% | 373 |
|
|
2021
Q2 | $130K | Hold |
800
| – | – | 0.02% | 306 |
|
|
2021
Q1 | $97K | Sell |
800
-124
| -13% | -$15K | 0.01% | 327 |
|
|
2020
Q4 | $141K | Buy |
+924
| New | +$141K | 0.02% | 269 |
|
|
2019
Q2 | – | Sell |
-220
| Closed | -$8K | – | 568 |
|
|
2019
Q1 | $8K | Buy |
+220
| New | +$8K | ﹤0.01% | 570 |
|